Around 5.3 million people in England were given a NICE-recommended statin or ezetimibe by their GP to help reduce their ...

Myeloma UK joined with patients and clinicians to challenge the decision, and today NICE confirmed that Elrexfio will now be ...

The UK's National Institute for Health and Care Excellence (NICE) guidance supports the Boston Scientific HeartLogic platform ...

There is a lot of outrage that the new Alzheimer’s drug donanemab is being refused on the NHS. But there are good reasons for ...

For the second time in recent months, a U.K. agency said the limited benefits of a new Alzheimer’s drug do not justify its ...

Eli Lilly's treatment for early Alzheimer's was deemed too expensive for wide use by UK's cost-effectiveness body on ...

The National Institute for Health and Care Excellence (NICE) declined coverage for Kisunla in a draft guidance, deeming it ...

Donanemab, the most effective treatment yet for the disease, will be banned on the health service despite regulators ...

Nice said the platforms could ‘improve fracture detection on X-rays in urgent care without increasing the risk of incorrect ...

However, Enbridge (NYSE: ENB) has been a very safe bet over the decades. The Canadian pipeline and utility company has paid ...

Shares of SoFi Technologies ( SOFI 7.16%) rose nearly 8% in the final half-hour of trading. Shares fell yesterday after the company reported its third-quarter earnings report. SoFi reported $0.05 of ...

Overall, revenue at Crocs rose 1.6% to $1.06 billion. DTC sales increased 4.4%, while wholesale revenue fell 1.4%. Adjusted ...